Expression and prognostic value of α-, ß-, and γ-catenins in differentiated thyroid carcinoma

被引:35
作者
Böhm, J
Niskanen, L
Kiraly, K
Kellokoski, J
Eskelinen, M
Hollmen, S
Alhava, E
Kosma, VM
机构
[1] Univ Kuopio, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, FIN-70211 Kuopio, Finland
[3] Kuopio Univ Hosp, Dept Med & Clin Nutr, FIN-70211 Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Otorhinolaryngol, Oral & Maxillofacial Unit, FIN-70211 Kuopio, Finland
[5] Kuopio Univ Hosp, Dept Surg, FIN-70211 Kuopio, Finland
[6] Satakunta Cent Hosp, Dept Pathol, FIN-28500 Pori, Finland
关键词
D O I
10.1210/jc.85.12.4806
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Catenins (alpha, beta, and gamma) are a group of intracellular cell adhesion molecules that unite cytoskeleton with extracellular adhesion system. Abnormal expression of these molecules may have prognostic relevance in various carcinomas, including differentiated thyroid carcinoma (DTC). We have, therefore, evaluated the prognostic value of alpha-, beta-, and gamma -catenins along with traditional risk factors in 206 consecutive DTC patients by immunohistochemistry. Papillary carcinomas showed normal staining pattern for alpha-, beta-, and gamma -catenins in 124 (60%), 136 (67%), and 94 (46%) cases, respectively. Follicular carcinomas expressed alpha-, beta-, and gamma -catenins normally in 16 (48%), 18 (55%), and 8 (32%) cases, respectively. Follicular type of tumor showed more often reduced staining for all catenins than papillary carcinoma (P = 0.009, P = 0.004, and P = 0.002, respectively). Age (>60 yr) and pTNM-stage were related to reduced alpha- and beta -catenin expression levels (P = 0.027 and P = 0.026, respectively) and larger size of the tumor to reduced beta- and gamma -catenin expressions (P = 0.039 and P = 0.007, respectively). Nodal metastases at the time of primary treatment related to reduced alpha -catenin expression and distal metastases to reduced beta- and gamma -catenin staining signals (P = 0.022, P = 0.014, and P = 0.039, respectively). Reduced alpha -catenin associated with tumor recurrence (P = 0.002) and reduced beta -catenin with cancer-related mortality (P = 0.005). The multivariate analysis for recurrence-free survival showed that alpha -catenin and serum thyroglobulin level 1 yr after primary treatment were prognostic of recurrent disease (hazards ratio, 3.42, P = 0.022; and hazards ratio, 10.03, P = 0.0001). In addition, alpha -catenin retained its prognostic significance in low-stage patients (P = 0.0151). We propose that the evaluation of alpha -catenin expression by immunohistochemistry in DTC patients has prognostic value in addition to that obtained by traditional prognostic factors.
引用
收藏
页码:4806 / 4811
页数:6
相关论文
共 46 条
[21]  
2-1
[22]  
Jankowski JA, 1997, J CLIN PATHOL-MOL PA, V50, P289
[23]   Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival [J].
Jawhari, A ;
Jordan, S ;
Poole, S ;
Browne, P ;
Pignatelli, M ;
Farthing, MJG .
GASTROENTEROLOGY, 1997, 112 (01) :46-54
[24]   PROGNOSTIC IMPLICATIONS OF THE TALL CELL VARIANT OF PAPILLARY THYROID-CARCINOMA [J].
JOHNSON, TL ;
LLOYD, RV ;
THOMPSON, NW ;
BEIERWALTES, WH ;
SISSON, JC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (01) :22-27
[25]  
KADOWAKI T, 1994, CANCER RES, V54, P291
[26]   INTERACTION OF ALPHA-ACTININ WITH THE CADHERIN/CATENIN CELL-CELL ADHESION COMPLEX VIA ALPHA-CATENIN [J].
KNUDSEN, KA ;
SOLER, AP ;
JOHNSON, KR ;
WHEELOCK, MJ .
JOURNAL OF CELL BIOLOGY, 1995, 130 (01) :67-77
[27]  
LIVOLSI VA, 1990, MAJOR PROBLEMS PATHO, V22
[28]   Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients [J].
Loh, KC ;
Greenspan, FS ;
Gee, L ;
Miller, TR ;
Yeo, PPB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3553-3562
[29]  
Nakanishi Y, 1997, ONCOLOGY, V54, P158
[30]   Tall cell variant of papillary thyroid carcinoma - A reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid [J].
Ostrowski, ML ;
Merino, MJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (08) :964-974